Effect of sustained-release long-acting intravitreal dexamethasone implant in patients of non-proliferative diabetic retinopathy undergoing phacoemulsification: A randomized controlled trial
Gupta P, Ram J, Kumar M, Agarwal A, Gupta V, Singh R, Bansal R, Katoch D, Dogra M, Gupta A. Effect of sustained-release long-acting intravitreal dexamethasone implant in patients of non-proliferative diabetic retinopathy undergoing phacoemulsification: A randomized controlled trial. Indian Journal Of Ophthalmology 2021, 69: 3263-3272. PMID: 34708785, PMCID: PMC8725102, DOI: 10.4103/ijo.ijo_749_21.Peer-Reviewed Original ResearchConceptsEarly Treatment Diabetic Retinopathy StudyDexamethasone drug delivery systemStandard of careIntravitreal dexamethasone implantLaser flare meterDexamethasone implantIntraocular pressureOptical coherence tomographyMacular thicknessIntraocular lensDiabetic retinopathyDexamethasone groupTreatment Diabetic Retinopathy StudyNon-proliferative diabetic retinopathyStatistically significant interactionCentral macular thicknessIOP scoreDiabetic Retinopathy StudyStandard of care groupVisual acuity scoresType 2 diabetes mellitusRescue interventionCo-primary outcomesFlare meterMacular edema
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply